NeuroBo Pharmaceuticals Inc (NRBO)
4.60
+0.36
(+8.49%)
USD |
NASDAQ |
May 16, 16:00
4.60
0.00 (0.00%)
After-Hours: 20:00
NeuroBo Pharmaceuticals Price to Book Value: 2.240 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 15, 2024 | 2.064 |
May 14, 2024 | 2.001 |
May 13, 2024 | 1.962 |
May 10, 2024 | 1.928 |
May 09, 2024 | 1.945 |
May 08, 2024 | 1.914 |
May 07, 2024 | 1.870 |
May 06, 2024 | 1.850 |
May 03, 2024 | 1.840 |
May 02, 2024 | 1.816 |
May 01, 2024 | 1.792 |
April 30, 2024 | 1.582 |
April 29, 2024 | 1.573 |
April 26, 2024 | 1.529 |
April 25, 2024 | 1.490 |
April 24, 2024 | 1.509 |
April 23, 2024 | 1.470 |
April 22, 2024 | 1.519 |
April 19, 2024 | 1.641 |
April 18, 2024 | 1.675 |
April 17, 2024 | 1.685 |
April 16, 2024 | 1.656 |
April 15, 2024 | 1.719 |
April 12, 2024 | 1.758 |
April 11, 2024 | 1.743 |
Date | Value |
---|---|
April 10, 2024 | 1.733 |
April 09, 2024 | 1.719 |
April 08, 2024 | 1.933 |
April 05, 2024 | 1.889 |
April 04, 2024 | 1.894 |
April 03, 2024 | 1.894 |
April 02, 2024 | 1.914 |
April 01, 2024 | 1.977 |
March 28, 2024 | 1.203 |
March 27, 2024 | 1.276 |
March 26, 2024 | 1.264 |
March 25, 2024 | 1.289 |
March 22, 2024 | 1.311 |
March 21, 2024 | 1.347 |
March 20, 2024 | 1.291 |
March 19, 2024 | 1.208 |
March 18, 2024 | 1.276 |
March 15, 2024 | 1.353 |
March 14, 2024 | 1.338 |
March 13, 2024 | 1.314 |
March 12, 2024 | 1.432 |
March 11, 2024 | 1.506 |
March 08, 2024 | 1.576 |
March 07, 2024 | 1.605 |
March 06, 2024 | 1.650 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3233
Minimum
Nov 07 2022
59.61
Maximum
Apr 13 2020
6.189
Average
2.721
Median
May 31 2019
Price to Book Value Benchmarks
Eli Lilly and Co | 57.12 |
SIGA Technologies Inc | 3.403 |
Vanda Pharmaceuticals Inc | 0.5975 |
Tenon Medical Inc | 4.216 |
NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
Price | 4.60 |
Earnings Yield | -70.00% |
Market Cap | 22.57M |